{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:34:39Z","timestamp":1789475679537,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"DOI":"10.1186\/s12969-025-01116-0","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T10:19:44Z","timestamp":1749205184000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Juvenile localized scleroderma: a large retrospective cohort study from a tertiary care center"],"prefix":"10.1186","volume":"23","author":[{"given":"Bugra Han","family":"Egeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnathan","family":"Dallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana B.","family":"Reusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina S.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Sundel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Vleugels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7516-0848","authenticated-orcid":false,"given":"Fatma","family":"Dedeoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"issue":"3","key":"1116_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1080\/14397595.2020.1816612","volume":"31","author":"A Dag","year":"2021","unstructured":"Dag A, Tarakci E, Adrovic A, Kasapcopur O. Effects of sense and functionality changes in the hands on activity and participation in patients with juvenile scleroderma. Mod Rheumatol. 2021;31(3):657\u201368.","journal-title":"Mod Rheumatol"},{"issue":"1","key":"1116_CR2","first-page":"73","volume":"24","author":"LS Peterson","year":"1997","unstructured":"Peterson LS, Nelson AM, Su WP, Mason T, O\u2019Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in olmsted County 1960\u20131993. J Rheumatol [Internet]. 1997;24(1):73\u201380.","journal-title":"J Rheumatol [Internet]"},{"issue":"1","key":"1116_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/2397198318798588","volume":"4","author":"T Beukelman","year":"2019","unstructured":"Beukelman T, Xie F, Foeldvari I. The prevalence of localised scleroderma in childhood assessed in the administrative claims data from the united States. J Scleroderma Relat Disorders. 2019;4(1):77\u20138.","journal-title":"J Scleroderma Relat Disorders"},{"issue":"2","key":"1116_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/acr.20070","volume":"62","author":"AL Herrick","year":"2010","unstructured":"Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM. Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res (Hoboken). 2010;62(2):213\u20138.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1116_CR5","unstructured":"Zulian F, Martini G. Preliminary classification criteria for juvenile systemic sclerosis. In: Proceedings of the II Workshop on Nomenclature and Diagnostic Criteria for Juvenile Scleroderma Syndromes; 2005."},{"key":"1116_CR6","doi-asserted-by":"crossref","unstructured":"Peterson LS, Nelson AM, Su WPD. Classification of morphea (Localized Scleroderma). Mayo Clin Proc. 1995;70(11):1068\u201376.","DOI":"10.4065\/70.11.1068"},{"issue":"1","key":"1116_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3899\/jrheum.090708","volume":"37","author":"SC Li","year":"2010","unstructured":"Li SC, Feldman BM, Higgins GC, Haines KA, Punaro MG, O\u2019Neil KM. Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists. J Rheumatol. 2010;37(1):175\u201381.","journal-title":"J Rheumatol"},{"issue":"5","key":"1116_CR8","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.jaad.2010.09.006","volume":"65","author":"BA Zwischenberger","year":"2011","unstructured":"Zwischenberger BA, Jacobe HT. A systematic review of morphea treatments and therapeutic algorithm. J Am Acad Dermatol [Internet]. 2011;65(5):925\u201341.","journal-title":"J Am Acad Dermatol [Internet]"},{"issue":"9","key":"1116_CR9","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1002\/art.21264","volume":"52","author":"F Zulian","year":"2005","unstructured":"Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J, et al. Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum. 2005;52(9):2873\u201381.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"1116_CR10","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.1093\/rheumatology\/keab238","volume":"60","author":"SC Li","year":"2021","unstructured":"Li SC, Higgins GC, Chen M, Torok KS, Rabinovich CE, Stewart K, et al. Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma. Rheumatology (Oxford). 2021;60(12):5724\u201333.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1116_CR11","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/bjd.12606","volume":"169","author":"M Piram","year":"2013","unstructured":"Piram M, McCuaig CC, Saint-Cyr C, Marcoux D, Hatami A, Haddad E, et al. Short- and long-term outcome of linear morphoea in children. Br J Dermatol. 2013;169(6):1265\u201371.","journal-title":"Br J Dermatol"},{"issue":"7","key":"1116_CR12","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/acr.23101","volume":"69","author":"K Ardalan","year":"2017","unstructured":"Ardalan K, Zigler CK, Torok KS. Predictors of longitudinal quality of life in juvenile localized scleroderma. Arthritis Care Res (Hoboken). 2017;69(7):1082\u201387.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1116_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/pde.13281","volume":"35","author":"MM Tollefson","year":"2018","unstructured":"Tollefson MM, Chiu YE, Brandling-Bennett HA, Pope E. Discordance of pediatric morphea treatment by pediatric dermatologists. Pediatr Dermatol. 2018;35(1):47\u201354.","journal-title":"Pediatr Dermatol"},{"issue":"7","key":"1116_CR14","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.autrev.2018.02.004","volume":"17","author":"G Martini","year":"2018","unstructured":"Martini G, Fadanelli G, Agazzi A, Vittadello F, Meneghel A, Zulian F. Disease course and long-term outcome of juvenile localized scleroderma: experience from a single pediatric rheumatology centre and literature review. Autoimmun Rev. 2018;17(7):727\u201334.","journal-title":"Autoimmun Rev [Internet]"},{"key":"1116_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12519-019-00320-9","volume":"16","author":"SC Li","year":"2020","unstructured":"Li SC, Zheng RJ. Overview of juvenile localized scleroderma and its management. World J Pediatr. 2020;16:5\u201318.","journal-title":"World J Pediatr"},{"issue":"1","key":"1116_CR16","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","volume":"136","author":"Y Uziel","year":"2000","unstructured":"Uziel Y, Feldman BM, Krafchik BR, Yeung RSM, Laxer RM. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr [Internet]. 2000;136(1):91\u20135.","journal-title":"J Pediatr [Internet]"},{"issue":"5","key":"1116_CR17","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","volume":"155","author":"L Weibel","year":"2006","unstructured":"Weibel L, Sampaio MC, Visentin MT, Howell KJ, Woo P, Harper JI. Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children. Br J Dermatol. 2006;155(5):1013\u201320.","journal-title":"Br J Dermatol"},{"issue":"7","key":"1116_CR18","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/art.30264","volume":"63","author":"F Zulian","year":"2011","unstructured":"Zulian F, Martini G, Vallongo C, Vittadello F, Falcini F, Patrizi A, et al. Methotrexate treatment in juvenile localized scleroderma: A randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2011;63(7):1998\u20132006.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"1116_CR19","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/acr.21687","volume":"64","author":"SC Li","year":"2012","unstructured":"Li SC, Torok KS, Pope E, Dedeoglu F, Hong S, Jacobe HT, et al. Development of consensus treatment plans for juvenile localized scleroderma: A roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken). 2012;64(8):1175\u201385.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"1116_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1136\/annrheumdis-2018-214697","volume":"78","author":"F Zulian","year":"2019","unstructured":"Zulian F, Culpo R, Sperotto F, Anton J, Avcin T, Baildam EM, et al. Consensus-based recommendations for the management of juvenile localised scleroderma. Ann Rheum Dis. 2019;78(8):1019\u201324.","journal-title":"Ann Rheum Dis"},{"key":"1116_CR21","doi-asserted-by":"crossref","unstructured":"de Albuquerque JV, Andriolo BNG, Vasconcellos MRA, Civile VT, Lyddiatt A, Trevisani VFM. Interventions for morphea. Vol. 2019, Cochrane database of systematic reviews. John Wiley and Sons Ltd; 2019.","DOI":"10.1002\/14651858.CD005027.pub5"},{"issue":"5","key":"1116_CR22","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1111\/bjd.17312","volume":"180","author":"KL Kurzinski","year":"2019","unstructured":"Kurzinski KL, Zigler CK, Torok KS. Prediction of disease relapse in a cohort of paediatric patients with localized scleroderma. Br J Dermatol. 2019;180(5):1183\u20139.","journal-title":"Br J Dermatol"},{"issue":"12","key":"1116_CR23","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3899\/jrheum.081284","volume":"36","author":"T Arkachaisri","year":"2009","unstructured":"Arkachaisri T, Vilaiyuk S, Li S, O\u2019Neill KM, Pope E, Higgins GC, et al. The localized scleroderma skin severity index and physician global assessment of disease activity: A work in progress toward development of localized scleroderma outcome measures. J Rheumatol. 2009;36(12):2819\u201329.","journal-title":"J Rheumatol"},{"key":"1116_CR24","unstructured":"R Core Team. R: A language and environment for statistical computing. Version 3.6.0. R Foundation for Statistical Computing. 2019. Available at: https:\/\/www.r-project.org\/"},{"issue":"2","key":"1116_CR25","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/ced.14390","volume":"46","author":"Y Argobi","year":"2021","unstructured":"Argobi Y, Smith GP. Analysis of the first 5 years of an interdisciplinary Rheumatology\u2013Dermatology clinic. Clin Exp Dermatol. 2021;46(2):270\u20135.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"1116_CR26","first-page":"37","volume":"8","author":"FG Demirkan","year":"2020","unstructured":"Demirkan FG, Topkarci Z, Karadag SG, Sonmez HE, Cakmak F, Ayaz NA. Towards a combined pediatric rheumatology-dermatology clinic: One-year experience. North Clin Istanb. 2020;8(1):37.","journal-title":"North Clin Istanb"},{"issue":"5","key":"1116_CR27","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/1203475416649138","volume":"20","author":"M Samycia","year":"2016","unstructured":"Samycia M, McCourt C, Shojania K, Au S. Experiences from a combined dermatology and rheumatology clinic: A retrospective review. J Cutan Med Surg [Internet]. 2016;20(5):486\u20139.","journal-title":"J Cutan Med Surg [Internet]"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01116-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-025-01116-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-025-01116-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T10:19:46Z","timestamp":1749205186000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-025-01116-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1116"],"URL":"https:\/\/doi.org\/10.1186\/s12969-025-01116-0","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"2 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for the lack of informed consent was obtained through the institutional review board at Boston Children\u2019s Hospital submission number IRB00000352 for analyzing deidentified retrospective patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"63"}}